To ensure the best possible supply of drugs, it is essential that doctors and the pharmaceutical industry work together.
The individual disclosure of payments in kind promotes trust among the parties collaborating.
The disclosure obligation defined in the Pharmig code of conduct concerns payments in kind in connection with:
• Research and development
• Donations and funding
• Services and consulting services including expenses
The disclosure refers to records of payments in kind related to prescription medicines.
Sanova supports patient organisations in their programming and activities. We make contributions in the form of simple memberships, donations and sponsoring.
Sanova publishes these collaborations in accordance with the EFPIA Code of Practice for Relationships Between the Pharmaceutical Industry and Patient Organisations and the Pharmig code of conduct.